Synopsys and Ansys Provide Update Regarding Expected Timing of Acquisition Close
Synopsys (Nasdaq: SNPS) and Ansys (NASDAQ: ANSS) provided an update on their pending acquisition's regulatory approval status. The companies have successfully obtained merger clearance in all jurisdictions except China, where they are in advanced stages of obtaining approval from the State Administration for Market Regulation.
The companies emphasized that the transaction has been approved in other jurisdictions based on its merits and anticipated benefits for stakeholders and future technology innovation. They continue to work collaboratively with Chinese regulators to secure the final necessary approval.
Synopsys (Nasdaq: SNPS) e Ansys (NASDAQ: ANSS) hanno fornito un aggiornamento sullo stato dell'approvazione regolatoria della loro acquisizione in sospeso. Le aziende hanno ottenuto con successo l'autorizzazione alla fusione in tutte le giurisdizioni tranne che in Cina, dove sono nelle fasi avanzate per ottenere l'approvazione dalla State Administration for Market Regulation.
Le società hanno sottolineato che la transazione è stata approvata in altre giurisdizioni basandosi sui suoi meriti e sui benefici previsti per gli stakeholder e l'innovazione tecnologica futura. Continuano a collaborare con i regolatori cinesi per assicurarsi l'approvazione finale necessaria.
Synopsys (Nasdaq: SNPS) y Ansys (NASDAQ: ANSS) proporcionaron una actualización sobre el estado de la aprobación regulatoria de su adquisición pendiente. Las compañías han obtenido con éxito la autorización para la fusión en todas las jurisdicciones excepto en China, donde están en etapas avanzadas para obtener la aprobación de la Administración Estatal para la Regulación del Mercado.
Las empresas enfatizaron que la transacción ha sido aprobada en otras jurisdicciones basándose en sus méritos y los beneficios anticipados para las partes interesadas y la futura innovación tecnológica. Continúan trabajando de manera colaborativa con los reguladores chinos para asegurar la aprobación final necesaria.
Synopsys (나스닥: SNPS)와 Ansys (나스닥: ANSS)는 진행 중인 인수 건의 규제 승인 현황에 대해 업데이트를 제공했습니다. 두 회사는 중국을 제외한 모든 관할 구역에서 합병 승인을 성공적으로 획득했으며, 중국에서는 국가시장감독관리총국(State Administration for Market Regulation)의 승인을 받기 위한 최종 단계에 있습니다.
양사는 거래가 다른 관할 구역에서 그 타당성과 이해관계자 및 미래 기술 혁신에 대한 예상 이익을 근거로 승인되었음을 강조했습니다. 또한 중국 규제 당국과 협력하여 최종 필요한 승인을 확보하기 위해 계속 노력하고 있습니다.
Synopsys (Nasdaq : SNPS) et Ansys (NASDAQ : ANSS) ont fourni une mise à jour sur l'état de l'approbation réglementaire de leur acquisition en cours. Les entreprises ont obtenu avec succès l'autorisation de fusion dans toutes les juridictions sauf en Chine, où elles sont en phase avancée d'obtention de l'approbation de l'Administration d'État pour la Régulation du Marché.
Les sociétés ont souligné que la transaction a été approuvée dans d'autres juridictions en se basant sur ses mérites et les bénéfices anticipés pour les parties prenantes ainsi que pour l'innovation technologique future. Elles continuent de collaborer étroitement avec les régulateurs chinois pour obtenir l'approbation finale nécessaire.
Synopsys (Nasdaq: SNPS) und Ansys (NASDAQ: ANSS) haben ein Update zum Stand der behördlichen Genehmigung ihrer bevorstehenden Übernahme gegeben. Die Unternehmen haben die Fusionsfreigabe in allen Rechtsgebieten außer China erfolgreich erhalten, wo sie sich in fortgeschrittenen Verhandlungen mit der State Administration for Market Regulation befinden.
Die Unternehmen betonten, dass die Transaktion in anderen Rechtsgebieten aufgrund ihrer Verdienste und der erwarteten Vorteile für die Beteiligten und zukünftige technologische Innovationen genehmigt wurde. Sie arbeiten weiterhin eng mit den chinesischen Regulierungsbehörden zusammen, um die endgültige erforderliche Genehmigung zu erhalten.
- Merger clearance already received in all jurisdictions except China
- Advanced stage reached in obtaining final regulatory approval from China
- Transaction recognized for significant benefits to stakeholders and technology innovation
- Final regulatory approval from China still pending
- Timing uncertainty for transaction completion due to pending Chinese regulatory approval
We have already received merger clearance in every jurisdiction other than
About Synopsys
Catalyzing the era of pervasive intelligence, Synopsys, Inc. (Nasdaq: SNPS) delivers trusted and comprehensive silicon to systems design solutions, from electronic design automation to silicon IP and system verification and validation. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.
About Ansys
Our Mission: Powering Innovation that Drives Human Advancement™
When visionary companies need to know how their world-changing ideas will perform, they close the gap between design and reality with Ansys simulation. For more than 50 years, Ansys software has enabled innovators across industries to push boundaries by using the predictive power of simulation. From sustainable transportation to advanced semiconductors, from satellite systems to life-saving medical devices, the next great leaps in human advancement will be powered by Ansys.
Ansys and any and all ANSYS, Inc. brand, product, service and feature names, logos and slogans are registered trademarks or trademarks of ANSYS, Inc. or its subsidiaries in
© 2025 Synopsys, Inc. All rights reserved. Synopsys, the Synopsys logo, and other Synopsys trademarks are available at https://www.synopsys.com/company/legal/trademarks-brands.html. Other company or product names may be trademarks of their respective owners.
ANSS–G
Investor Contacts
Trey
Synopsys, Inc.
650-584-4289
Synopsys-ir@synopsys.com
Kelsey DeBriyn
ANSYS, Inc.
724-820-3927
kelsey.debriyn@ansys.com
Editorial Contacts
Cara Walker
Synopsys, Inc.
650-584-5000
corp-pr@synopsys.com
Mary Kate Joyce
ANSYS, Inc.
724-820-4368
MaryKate.Joyce@ansys.com
Cautionary Statement Regarding Forward-Looking Statements
This communication may contain certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Synopsys and Ansys, including, but not limited to, statements regarding the anticipated timing of the closing thereof and the regulatory approvals required for completion of the proposed transaction. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions or the negatives of these words or other comparable terminology to convey uncertainty of future events or outcomes.
Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties and other factors that could cause actual future events to differ materially from the forward-looking statements in this communication, including, but not limited to: (i) the completion of the proposed transaction on anticipated terms and timing, (ii) the failure to satisfy the conditions to the consummation of the proposed transaction, including the receipt of certain governmental and regulatory approvals on the terms expected, in a timely manner, or at all, (iii) the risk that such regulatory approvals may result in the imposition of conditions that could adversely affect, following completion of the proposed transaction (if completed), the combined company or the expected benefits of the proposed transaction, (iv) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (v) the effect of the pendency of the proposed transaction on Ansys' or Synopsys' business relationships, competition, business, financial condition, and operating results, (vi) risks that the proposed transaction disrupts current plans and operations of Ansys or Synopsys and the ability of Ansys or Synopsys to retain and hire key personnel, (vii) risks related to diverting either management team's attention from ongoing business operations of Ansys or Synopsys, (viii) the outcome of any legal proceedings that may be instituted against Ansys or Synopsys related to the merger agreement or the proposed transaction, (ix) the ability of Synopsys to successfully integrate Ansys' operations and product lines, (x) the ability of Synopsys to implement its plans, forecasts, expected financial performance and other expectations with respect to Ansys' business or the combined business after the completion of the proposed transaction and realize the benefits expected from the proposed transaction (if completed), as well as manage the scope and size of the combined company, (xi) risks associated with third party contracts containing consent and/or other provisions that may be triggered by the proposed transaction, (xii) uncertainty in the macroeconomic and geopolitical environment and its potential impact on the semiconductor and electronics industries, (xiii) uncertainty in the growth of the semiconductor, electronics and artificial intelligence industries, (xiv) the highly competitive industries in which Synopsys and Ansys operate, (xv) actions by the
These risks, uncertainties and factors, as well as other risks associated with the proposed transaction, are more fully discussed in the proxy statement/prospectus filed with the SEC in connection with the proposed transaction. While the list of risks, uncertainties and factors presented here, and the list of risks presented in the proxy statement/prospectus, are considered representative, no such list is exhaustive. Unlisted risks, uncertainties and factors may present significant additional obstacles to the realization of forward-looking statements.
You should carefully consider the foregoing factors and the other risks and uncertainties that affect the businesses of Synopsys and Ansys described in the "Risk Factors" section of their respective Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other documents filed by either of them from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond Synopsys' and Ansys' control, and are not guarantees of future results. Readers are cautioned not to put undue reliance on forward-looking statements, and Synopsys and Ansys assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law. Neither Synopsys nor Ansys gives any assurance that either Synopsys or Ansys will achieve its expectations.
View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-and-ansys-provide-update-regarding-expected-timing-of-acquisition-close-302493608.html
SOURCE Ansys
FAQ
What is the current status of Synopsys' acquisition of Ansys (NASDAQ: ANSS)?
Which regulatory approvals are still pending for the Synopsys-Ansys merger?
How many regulatory approvals has the Synopsys-Ansys deal received so far?
What is the progress of Chinese regulatory approval for the Synopsys-Ansys acquisition?
What benefits are expected from the Synopsys-Ansys merger?
